© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
High Cost Impacts PCSK9 Inhibitor Access
Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.
Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.
Related Content:
